BCL2 Inhibition Reveals a Dendritic Cell– Specific Immune Checkpoint That Controls Tumor Immunosurveillance
- Liwei Zhao
- , Peng Liu
- , Misha Mao
- , Shuai Zhang
- , Camille Bigenwald
- , Charles Antoine Dutertre
- , Christian H.K. Lehmann
- , Hui Pan
- , Nicolas Paulhan
- , Lukas Amon
- , Aitziber Buqué
- , Takahiro Yamazaki
- , Lorenzo Galluzzi
- , Benoit Kloeckner
- , Aymeric Silvin
- , Yuhong Pan
- , Hui Chen
- , Ai Ling Tian
- , Pierre Ly
- , Diana Dudziak
- Centre de Recherche des Cordeliers
- Université Paris-Sud
- Université Paris-Saclay
- Zhejiang University
- Huazhong University of Science and Technology
- Gustave Roussy Cancer Campus
- Center of Clinical Investigations in Biotherapies of Cancer (CICBT)
- Friedrich-Alexander University Erlangen-Nürnberg
- Medical Immunology Campus Erlangen (MICE)
- Deutsches Zentrum für Immuntherapie (DZI)
- Comprehensive Cancer Center Erlangen-EMN
- Cornell University
- Weill Cornell Medical College
- Assistance publique – Hôpitaux de Paris
Research output: Contribution to journal › Article › peer-review
46
Scopus
citations